Emerald BioStructures (Formerly deCODE biostructures) Publication in Nature Biotechnology Details Discovery of Allosteric Small Molecule Modulators of PDE4 with Reduced Side Effects
12/28/2009 8:39:53 AM
BAINBRIDGE ISLAND, Wash.--(BUSINESS WIRE)--Emerald BioStructures (formerly deCODE biostructures) announced today a publication in the December 27, 2009 advance online issue of Nature Biotechnology, detailing the application of structure-based drug design (SBDD) to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established the structural basis of PDE4 regulation through crystal structures of the PDE4 regulatory domain in contact with small molecules.
comments powered by